Report in 12 hours
Booked 5 times
Anti-Phospholipid Antibody
Assessing Autoimmune Response for Comprehensive Vascular and Rheumatologic Health Insight
৳1600
৳2000
20% OFF
Sample Type
blood
Fasting Required
No
Description
Antiphospholipid syndrome, or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by antiphospholipid antibodies. APS provokes blood clots (thrombosis) in both arteries and veins as well as pregnancy-related complications such as miscarriage, stillbirth, preterm delivery, and severe preeclampsia. Although the exact etiology of APS is still not clear.
Covid Safety
Assured
Free Report
Counselling
Recommended for You
How our test process works!
Anti-Phospholipid Antibodies (aPL) are autoantibodies that target phospholipid-binding proteins, potentially causing hypercoagulability and vascular complications. Testing for aPL aids in diagnosing antiphospholipid syndrome (APS) and assessing the risk of thrombotic events and pregnancy complications. Positive results may necessitate anticoagulant therapy and close monitoring.
Risk assessment for Anti-Phospholipid Antibody (aPL) testing involves considering potential false-positive or false-negative results, ensuring proper sample collection and handling to prevent contamination, and interpreting results in conjunction with clinical symptoms and medical history for accurate diagnosis of autoimmune conditions such as antiphospholipid syndrome (APS).
Anti-Phospholipid Antibody (aPL) testing typically reports results qualitatively as positive or negative for the presence of autoantibodies targeting phospholipid-binding proteins. Positivity indicates the presence of aPL, suggesting an increased risk of thrombotic events and pregnancy complications, particularly in the context of antiphospholipid syndrome (APS). Quantitative results may also be provided, indicating antibody levels above or below a specified threshold.
Interpretation of Anti-Phospholipid Antibody (aPL) testing involves assessing the presence or absence of antibodies targeting phospholipid-binding proteins. Positive results indicate an increased risk of thrombotic events and pregnancy complications, suggesting a diagnosis of antiphospholipid syndrome (APS). Clinical correlation with symptoms and medical history is essential for accurate diagnosis and treatment decisions.
The Anti-Phospholipid Antibody (aPL) test requires a blood sample, typically collected via venipuncture, to detect autoantibodies targeting phospholipid-binding proteins. Serum or plasma is extracted from the blood sample and analyzed using immunoassay techniques, aiding in the diagnosis and management of conditions such as antiphospholipid syndrome (APS). Proper sample collection and handling are crucial for accurate test results.
Frequently Asked Question
Symptoms can vary widely and depend on the organs affected. Common symptoms include:
- Blood clots in arteries or veins (e.g., deep vein thrombosis, pulmonary embolism)
- Recurrent miscarriages or fetal loss
- Neurological symptoms (e.g., stroke, seizures)
- Skin conditions (e.g., livedo reticularis)
- Testing for the presence of APAs (e.g., lupus anticoagulant, anticardiolipin antibodies, anti-β2 glycoprotein I antibodies) on two or more occasions at least 12 weeks apart.
- Clinical assessment to confirm symptoms associated with APS.
Treatment aims to prevent blood clots and manage associated symptoms:
- Anticoagulant medications (e.g., heparin, warfarin) to prevent blood clots.
- Management of other conditions associated with APS (e.g., high blood pressure, diabetes).
- Pregnancy management to reduce the risk of complications.
APS is a chronic condition without a cure. Treatment focuses on managing symptoms, preventing complications, and improving quality of life.
With appropriate treatment, many people with APS can lead normal lives. However, the prognosis depends on the severity of symptoms, response to treatment, and any associated conditions.
Lifestyle changes such as maintaining a healthy weight, regular exercise, and avoiding smoking can help reduce the risk of complications associated with APS.
While APS itself is not inherited, there may be a genetic predisposition to autoimmune diseases in general, which could contribute to the development of APS.
It's important to work closely with a healthcare team, including rheumatologists, hematologists, and obstetricians, for comprehensive management and treatment of APS.
Anti-phospholipid antibodies are a group of autoantibodies that target phospholipid-binding proteins in the body. They are associated with an increased risk of abnormal blood clotting (thrombosis) and pregnancy complications.
APAs are primarily associated with:
- Antiphospholipid syndrome (APS): A systemic autoimmune disorder characterized by recurrent blood clots and/or pregnancy complications.
- Non-criteria manifestations: These include neurological disorders, heart valve abnormalities, and skin conditions.
Report in 12 hours
Booked 5 times
Anti-Phospholipid Antibody
Assessing Autoimmune Response for Comprehensive Vascular and Rheumatologic Health Insight
৳1600
৳2000
20% OFF
Sample Type
blood
Fasting Required
No
Description
Antiphospholipid syndrome, or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by antiphospholipid antibodies. APS provokes blood clots (thrombosis) in both arteries and veins as well as pregnancy-related complications such as miscarriage, stillbirth, preterm delivery, and severe preeclampsia. Although the exact etiology of APS is still not clear.
Covid Safety
Assured
Free Report
Counselling